bibliographic entry 6949509 [be/6949509]
https://w3id.org/oc/corpus/be/6949509

is a

• bibliographic reference

content

• Johnson & Johnson Pharmaceutical Research & Development. L.L.C. An efficacy, safety, and tolerability study of canagliflozin (JNJ-28431754) in patients with type 2 diabetes. National Library of Medicine (US), 2000. https://clinicaltrials.gov/show/NCT00642278.

references

• https://w3id.org/oc/corpus/br/5659508